Skip to main content

Table 1 Baseline charateristics of participants (n = 37)

From: Effect of cilostazol on arterial stiffness and vascular adhesion molecules in type 2 diabetic patients with metabolic syndrome: a randomised, double-blind, placebo-controlled, crossover trial

Characteristic

Mean ± SD (or N/%)

Age (years)

61.2 ± 6.7

Male sex (n/%)

15 (40.5%)

Duration of diabetes (years)

10 ± 6

Hypertension

32 (86.5%)

Dyslipidemia

14 (37.8%)

Current smoker

13 (35.1%)

BMI (kg/m2)

26.2 ± 2.9

Waist circumference (cm)

92.5 ± 8.0

Systolic blood pressure (mmHg)

131.9 ± 11.8

Diastolic blood pressure (mmHg)

79.2 ± 11.4

Fasting glucose (mg/dL)

133.4 ± 27.1

HbA1c (%)*

7.1 ± 1.1

Fasting insulin (μIU/mL)*

11.6 ± 1.6

HOMA-IR*

3.8 ± 1.6

QUICKI

0.32 ± 0.02

Total cholesterol (mg/dL)

155.2 ± 25.2

Triglyceride (mg/dL)*

131.1 ± 1.7

HDL-C (mg/dL)

46.2 ± 9.9

LDL-C (mg/dL)

91.6 ± 21.2

hsCRP (mg/L)*

1.07 ± 2.65

Mean baPWV (cm/sec)

1591.4 ± 192.6

Adiponectin (ng/mL)*

8.86 ± 1.87

IL-6 (pg/mL)*

3.99 ± 2.94

TNF-α (ng/dL)*

6.36 ± 1.27

MCP-1 (ng/dL)*

590.2 ± 1.63

sVCAM-1 (ng/dL)

1224.4 ± 267.6

sICAM-1 (ng/dL)*

169.7 ± 1.29

  1. HOMA-IR, homeostasis model assessment of insulin resistance, QUICKI quantitative insulin sensitivity check index, hsCRP high sensitivity C-reactive protein, baPWV brachial-ankle pulse wave velocity, IL-6 interleukin-6, TNF-α tumor necrosis factor-alpha, MCP-1 monocyte chemotactic protein-1, sVCAM-1 soluble vascular cellular adhesion molecule-1, sICAM-1 soluble intercellular adhesion molecule-1.
  2. Data are presented as the mean ± SD. *Geometric mean ± SD.